Cynosure Management, LLC Glaukos Corp Transaction History
Cynosure Management, LLC
- $680 Million
- Q3 2024
A detailed history of Cynosure Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Cynosure Management, LLC holds 2,854 shares of GKOS stock, worth $435,720. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,854Holding current value
$435,720% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
341Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.23 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$897 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$333 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$298 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$250 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.27B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...